NEW YORK–(BUSINESS WIRE)– #FDA–Eyenovia has submitted an NDA to the FDA for MydCombi, a unique fixed combination mydriatic (pupil dilation) agent delivered by the Optejet dispenser.
Author: Business Wire
Ocular TherapeutixTM Announces Exercise of Underwriters’ Option to Purchase Additional Shares
BEDFORD, Mass.–(BUSINESS WIRE)—- $OCUL #OCUTX–Ocular Therapeutix™, Inc. (Nasdaq: OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today…
Global Laser-Assisted In-Situ Keratomileusis (LASIK) Surgery Market Research 2020-2024 | Post-Pandemic Industry Planning Structure by Technavio
LONDON–(BUSINESS WIRE)– #GlobalLaserAssistedInSituKeratomileusisLASIKSurgeryMarket–The Laser-Assisted In-Situ Keratomileusis (LASIK) Surgery Market will grow by $ 375.04 mn during 2020-2024
Eyewear Market to Accelerate at a CAGR of Almost 8% | Research Report by Technavio
LONDON–(BUSINESS WIRE)– #GlobalEyewearMarket–The Eyewear Market will grow by USD 57.69 bn during 2020-2024
Glaukos Announces Participation in J.P. Morgan Healthcare Conference
SAN CLEMENTE, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced that …
United Kingdom Spectacles and Googles Market Outlook to 2024 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “United Kingdom: Spectacles and Googles 2014-2024” report has been added to ResearchAndMarkets.com’s offering. This report forecasts the market evolution at an average annual rate of -6.5% to the level of 205,010 thousand e…
Ocular Therapeutix™ Announces Submission to the FDA of a Supplemental New Drug Application for DEXTENZA® (dexamethasone ophthalmic insert) for the Treatment of Ocular Itching Associated with Allergic Conjunctivitis
BEDFORD, Mass.–(BUSINESS WIRE)—- $OCUL #OCUTX–Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today a…
EyeSouth Partners Expands Presence in Houston with Eye Center of Texas Affiliation
ATLANTA–(BUSINESS WIRE)–EyeSouth Partners (“EyeSouth” or the “Company”) is pleased to announce that it has completed an affiliation with Eye Center of Texas (“ECT”). The affiliation represents EyeSouth’s third in the state of Texas and twentieth affi…
Medical Technology Company Heru, Inc. Completes FDA Registration Following a $2.7M Seed Round
MIAMI–(BUSINESS WIRE)–Heru, a Bascom Palmer Eye Institute medical technology company developing a next-generation AI platform for vision diagnostics and augmentation, today announces its class I listing with the U.S. Food and Drug Administration (FDA…
My Eyelab Opens New Stores in Houston Area
HOUSTON–(BUSINESS WIRE)–My Eyelab, a leading retail eye health provider offering accessible and affordable eye care and eyewear, recently opened its newest locations in Houston, Humble and Cypress, TX on December 14 and 21. The locations are as follo…
Azura Ophthalmics Announces Primary Endpoints Met in Topline Results from Phase 2 Trial of the Company’s Investigational Treatment for Contact Lens Discomfort
TEL AVIV, Israel & MELBOURNE, Australia–(BUSINESS WIRE)–Azura Ophthalmics Ltd., a clinical-stage company developing innovative therapies for Meibomian gland dysfunction (MGD) and related eye diseases, today announced topline results from a phase 2 cl…
Avellino Wins Prestigious Innovation Honors
MENLO PARK, Calif.–(BUSINESS WIRE)– #avellino–Avellino and Ulster University jointly honored with the highly-prestigious 2020 US-Ireland Research Innovation Award for rare genetic eye diseases.
Genentech’s Faricimab Meets Primary Endpoint and Shows Strong Durability Across Two Global Phase III Studies for Diabetic Macular Edema, a Leading Cause of Blindness
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) today announced positive topline results from two identically designed global Phase III studies, YOSEMITE and RHINE, evaluating its invest…
Ophthalmology Devices Market 2020-2024- Featuring Alcon Inc., Allergan Plc, Bausch Health Companies Inc., Among Others to Contribute to the Market Growth
LONDON–(BUSINESS WIRE)– #GlobalOphthalmologyDevicesMarket–The Ophthalmology Devices Market will grow by USD 13.03 bn during 2020-2024
Kala Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
WATERTOWN, Mass.–(BUSINESS WIRE)–Kala Pharmaceuticals, Inc. (NASDAQ:KALA), today announced that the Company granted non-statutory stock options to new employees as inducement awards outside the Company’s 2017 Equity Incentive Plan in accordance with …
Stanton Optical Opens New Store in Boise Area
BOISE, Idaho–(BUSINESS WIRE)–Stanton Optical, a leading full-service optical retailer offering accessible and affordable eye care and eyewear, opened its newest location in Boise on Monday, December 14. Located at 1405 N. Milwaukee Street, the new st…
Global Glass Lens Market | $3.6 Billion Growth During 2020-2024 | Technavio
LONDON–(BUSINESS WIRE)– #GlobalGlassLensMarket–The Glass Lens Market will grow by $ 3.59 bn during 2020-2024
Gyroscope Therapeutics and the University of Pennsylvania Announce Research Agreement to Develop Gene Therapies for Serious Eye Diseases
LONDON–(BUSINESS WIRE)– #GeneTherapy–Gyroscope Therapeutics and the University of Pennsylvania Announce Research Agreement to Develop Gene Therapies for Serious Eye Diseases.
Kubota Vision Provides Update on Kubota Glasses – Wearable Device for Myopia Control
SEATTLE–(BUSINESS WIRE)–Kubota Vision Inc. (Kubota Vision), a clinical-stage specialty ophthalmology company and wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd. (Tokyo 4596), today announced that the company achieved a milestone b…
IVERIC bio to Present at the 39th Annual J.P. Morgan Healthcare Conference
NEW YORK–(BUSINESS WIRE)–IVERIC bio announced that Glenn P. Sblendorio, CEO and President, will present at the 39th Annual J.P. Morgan Healthcare Conference on Jan. 14, 2021.